StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
FINEORG.NS$4586.50+2.11%
Fair $4586.50+0.0%

FINEORG.NS

Fine Organic Industries Limited

Basic Materials / Specialty ChemicalsNSE

$4586.50

+94.90 (+2.11%)

Fairly Valued+0.0%Fair Value $4586.50Fund rank 34/100 · Data gapFallback financials|
SA 40/C
F-Score: 3/9
Margin Compression

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $2.9B · quality 66.3/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 59/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Operating margin has declined for 3 consecutive years
Thesis & Journal · FINEORG.NSLocal privado en este navegador · Fine Organic Industries Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$140.6B

P/E

33.7x

↑

EV/EBITDA

23.1x

↑

ROE

15.7%

↑

Gross Margin

40.1%

↑

Debt/Equity

0.03

↓
52-Week Range$4587
$3856$5494

TradingView lightweight chart

FINEORG.NS price, volumen y niveles de valoración

Último $4,587Periodo +457.4%
Fair value: $4,587

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-7.9%

FCF CAGR

-10.7%

FCF margin

12.2%

FCF / Net income

0.69x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $23.66B · net income $4.17B · FCF $2.88B

2023-FY → 2026-FY

Gross margin

40.1%-1.0% pts

Operating margin

18.0%-8.0% pts

Net margin

17.6%-2.8% pts

FCF margin

12.2%-1.2% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$23.66B$23.66B$22.69B$21.23B$30.29B
Net Income$4.17B$4.17B$4.10B$4.12B$6.18B
EBITDA$6.03B$6.03B$6.10B$6.02B$8.91B
EPS——133.89134.34201.60
Gross Margin40.1%40.1%41.5%42.6%41.1%
Operating Margin18.0%18.0%20.3%22.5%26.1%
Net Margin17.6%17.6%18.1%19.4%20.4%
Balance Sheet
Debt/Equity0.030.030.000.000.02
Current Ratio8.498.49———
Cash Flow
Free Cash Flow$2.88B$2.88B$764.0M$5.48B$4.04B
Returns
ROE15.7%15.7%17.9%21.4%40.1%
Valuation
P/E33.7033.7030.9432.4221.36
EV/EBITDA23.1023.1020.5321.0514.27
P/B5.285.285.536.958.57
Growth & Yield
Revenue Growth4.3%4.3%6.9%-29.9%—
EPS Growth——-0.3%-33.4%—
Dividend Yield0.2%0.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -2.0%

Total return

-2.0%

Start / end P/E

n/dx → n/dx

EPS bridge

133.89 → n/d

Residual

-2.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.2%
Residual / FX / buybacks / cross-term-2.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.